Malaria Diagnostics Market - 2024-2031

June 2025 | 45 pages | ID: ME97343BAB28EN
DataM Intelligence

US$ 3,400.00 US$ 4,350.00 -22 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Malaria Diagnostics Marketis is growing with a CAGR of 5.30% during the forecast period 2026-2035.

The Malaria Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Malaria Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Type
    • Microscopy*
    • Rapid diagnostic tests
    • Molecular diagnostic tests
    • Other
By End User
  • Hospital*
  • Diagnostic Laboratory
  • Other
Regional Analysis for Malaria Diagnostics Market:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global Malaria Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet By Type
3.2. Market Snippet By End User
3.3. Market Snippet By Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers:
    4.1.1.1. The increasing technological developments
  4.1.2. Restraints:
    4.1.2.1. The problems associated with malaria diagnosis
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY TYPE

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
7.3. Market Attractiveness Index, By Type
  7.3.1. Microscopy*
      7.3.1.1.1. Introduction
      7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  7.3.2. Rapid diagnostic tests
  7.3.3. Molecular diagnostic tests
  7.3.4. Other

8. BY END USER

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  8.1.2. Market Attractiveness Index, By End User
8.2. Hospital*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Diagnostic Laboratory
8.4. Other

9. BY REGION

9.1. Introduction
  9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.2.5.1. U.S.
    9.2.5.2. Canada
    9.2.5.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.3.5.1. Germany
    9.3.5.2. U.K.
    9.3.5.3. France
    9.3.5.4. Italy
    9.3.5.5. Spain
    9.3.5.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.4.5.1. Brazil
    9.4.5.2. Argentina
    9.4.5.3. Rest of South America
9.5. Asia Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.5.5.1. China
    9.5.5.2. India
    9.5.5.3. Japan
    9.5.5.4. Australia
    9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. COMPETITIVE LANDSCAPE

10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking

11. COMPANY PROFILES

11.1. BioM?rieux SA*
  11.1.1. Company Overview
  11.1.2. Product Portfolio and Description
  11.1.3. Key Highlights
  11.1.4. Financial Overview
11.2. Abbott Laboratories
11.3. Bio-Rad Laboratories Inc.
11.4. Premier Medical Corporation Ltd
11.5. Siemens AG
11.6. Olympus Corporation
11.7. Access Bio. Inc
11.8. Atlas Medical
11.9. Meridian Bioscience Inc(*LIST NOT EXHAUSTIVE)

12. DATAM INTELLIGENCE

12.1. Appendix
12.2. About Us and Services
12.3. Contact Us


More Publications